BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3697936)

  • 1. Prognostic significance of mean cell volume in non-Hodgkin's lymphomas.
    Hauser L; Kurec A; Goldberg J; Dubowy RL; Davey FR
    Cancer; 1986 Jun; 57(12):2363-7. PubMed ID: 3697936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell volumes of normal and malignant mononuclear cells.
    Chapman EH; Kurec AS; Davey FR
    J Clin Pathol; 1981 Oct; 34(10):1083-90. PubMed ID: 6975780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
    Miettinen M; Franssila KO; Saxén E
    Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reed-Sternberg-like cells in low-grade lymphomas are transformed neoplastic cells of B-cell lineage.
    Shin SS; Ben-Ezra J; Burke JS; Sheibani K; Rappaport H
    Am J Clin Pathol; 1993 Jun; 99(6):658-62. PubMed ID: 8322699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
    Ersbøll J; Schultz HB; Hougaard P; Nissen NI; Hou-Jensen K
    Cancer; 1985 May; 55(10):2442-58. PubMed ID: 3986740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of nuclear form factor, area and diameter in non-Hodgkin's lymphomas and reactive lymph nodes.
    Crocker J; Jones EL; Curran RC
    J Clin Pathol; 1983 Mar; 36(3):298-302. PubMed ID: 6338055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
    Conlan MG; Bast M; Armitage JO; Weisenburger DD
    J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular renewal kinetics of malignant non-Hodgkin's lymphomas.
    Bremer K
    Recent Results Cancer Res; 1978; 65():5-11. PubMed ID: 370941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance.
    Byrne GE
    Cancer Treat Rep; 1977 Sep; 61(6):935-44. PubMed ID: 332357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Density distribution of human lymphocytes. II. Distribution patterns of malignant lymphocytes and their prognostic significance in patients with non-Hodgkin's lymphoma].
    Niederwieser D; Huber C; Lutz D; Weiser G; Theml H; Braunsteiner H
    Blut; 1982 Dec; 45(6):385-94. PubMed ID: 6890386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors.
    Raphael M; Gentilhomme O; Tulliez M; Byron PA; Diebold J
    Arch Pathol Lab Med; 1991 Jan; 115(1):15-20. PubMed ID: 1987908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.
    Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES
    J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
    Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
    Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The form factor of alpha-naphthyl acetate esterase-positive cells in non-Hodgkin's lymphomas and reactive lymph nodes.
    Crocker J; Jones EL; Curran RC
    J Clin Pathol; 1983 Mar; 36(3):303-6. PubMed ID: 6338056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification.
    Christensson B; Tribukait B; Linder IL; Ullman B; Biberfeld P
    Cancer; 1986 Sep; 58(6):1295-304. PubMed ID: 3742454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility and prognostic value of different non-Hodgkin's lymphoma classifications: study based on the clinicopathologic relations found in the EORTC trial (20751).
    De Wolf-Peeters C; Caillou B; Diebold J; van Heerde P; van Unnik JA; van den Oord JJ; van Glabbeke M; Somers R
    Eur J Cancer Clin Oncol; 1985 May; 21(5):579-84. PubMed ID: 4007023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [B-cell lymphomas (non-Hodgkin's lymphomas of B type) in children--morphologic and immunologic spectrum].
    Schwarze EW; Pileri S; Stein H; Palestro G; Tolksdorf G
    Klin Padiatr; 1982; 194(4):226-32. PubMed ID: 6982372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative study of histiocytic reticulum cells in diffuse and follicular non-Hodgkin's lymphomas.
    Crocker J; Jenkins R
    J Clin Pathol; 1984 Nov; 37(11):1222-6. PubMed ID: 6389602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.